We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) (ERICH)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01202864
First Posted: September 16, 2010
Last Update Posted: September 1, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Massachusetts General Hospital
Columbia University
University of Maryland
Georgetown University
Wake Forest University
Emory University
University of Miami
University of Illinois at Chicago
University of Texas, Southwestern Medical Center at Dallas
The University of Texas Health Science Center, Houston
The University of Texas Health Science Center at San Antonio
University of New Mexico
University of Arizona
University of Southern California
St. Luke's-Roosevelt Hospital Center
University of California, San Francisco
Duke University
University of Virginia
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
Daniel Woo, University of Cincinnati
September 14, 2010
September 16, 2010
September 1, 2017
August 1, 2010
July 31, 2017   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01202864 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
The purpose of this study is to find risk factors for hemorrhagic stroke, specifically intracerebral hemorrhage (ICH), among Caucasians, African Americans, and Hispanics.
Not Provided
Observational
Observational Model: Case-Control
Time Perspective: Other
Not Provided
Retention:   Samples With DNA
Description:
whole blood
Non-Probability Sample

Our purpose is to enroll 1000 cases of ICH among whites, 1000 cases of ICH among blacks, and 1000 cases of ICH among Hispanics.

3000 controls matched to cases by race/ethnicity, age (+/- 5 years), gender, and geographic location.

Intracerebral Hemorrhage
Not Provided
  • Cases
    3000 Cases
  • Controls
    3000 Controls

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
6000
August 1, 2017
July 31, 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

All cases must meet the following eligibility criteria:

  1. Age 18 years or greater, fulfillment of the criteria for intracerebral hemorrhage
  2. Resident for at least 6 months within 50 miles of the recruiting center
  3. No evidence of trauma, vascular malformation or aneurysm, or brain tumor as a cause of the hemorrhage
  4. Ability of the patient or legal representative to provide informed consent

Exclusion Criteria:

Exclusion Criteria:

  1. Malignancies leading to coagulopathy
  2. Hemorrhagic transformation of ischemic infarct
  3. Hemorrhage secondary to dural venous sinus thrombosis
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01202864
1008059
R01NS069763-01 ( Other Grant/Funding Number: NINDS )
No
Not Provided
Not Provided
Daniel Woo, University of Cincinnati
University of Cincinnati
  • Massachusetts General Hospital
  • Columbia University
  • University of Maryland
  • Georgetown University
  • Wake Forest University
  • Emory University
  • University of Miami
  • University of Illinois at Chicago
  • University of Texas, Southwestern Medical Center at Dallas
  • The University of Texas Health Science Center, Houston
  • The University of Texas Health Science Center at San Antonio
  • University of New Mexico
  • University of Arizona
  • University of Southern California
  • St. Luke's-Roosevelt Hospital Center
  • University of California, San Francisco
  • Duke University
  • University of Virginia
  • National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator: Daniel Woo, MD, MS University of Cincinnati
Principal Investigator: Matthew Flaherty, MD University of Cincinnati
University of Cincinnati
August 2017